Richard Scheller
Chief Tech/Sci/R&D Officer at BRIDGEBIO PHARMA, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Dr. Richard H. Scheller is an Independent Director at Alector, Inc., a Director, Chairman-Research & Development at BridgeBio Pharma LLC, an Independent Director at Oric Pharmaceuticals, Inc., a Chairman at DICE Molecules SV LLC, a Director, Chairman-Research & Development at BridgeBio Pharma, Inc., a Member at American Academy of Arts & Sciences, a Member at National Academy of Medicine of United States and a Member at National Academy of Sciences. He is on the Board of Directors at Maze Therapeutics, Inc., Alector, Inc., BridgeBio Pharma LLC, DiCE Molecules, Inc., 23andMe, Inc., Oric Pharmaceuticals, Inc., Dice Molecules Holdings LLC, Rafael Pharmaceuticals, Inc., BridgeBio Pharma, Inc. and Fine Arts Museums of San Francisco. Dr. Scheller was previously employed as an Independent Director by Xenon Pharmaceuticals, Inc., a Director & Chief Scientific Officer by Medrio, Inc., a Head-Genentech Research & Early Development by Roche Holding AG, an Executive VP-Research & Early Development by Genentech, Inc., and an Associate Professor by Stanford University. He also served on the board at Affinita Biotech, Inc. He received his undergraduate degree from the University of Wisconsin, a doctorate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from California Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BRIDGEBIO PHARMA, INC.
0.03% | 2023-02-15 | 53,822 ( 0.03% ) | 2 M $ | 2024-03-30 |
ALECTOR, INC.
0.05% | 2023-07-14 | 44,250 ( 0.05% ) | 266 385 $ | 2024-03-30 |
| 2023-09-05 | 237,476 ( 0.08% ) | 126 337 $ | 2024-03-30 |
Richard Scheller active positions
| Companies | Position | Start |
|---|---|---|
| ALECTOR, INC. | Director/Board Member | 2018-09-30 |
| BRIDGEBIO PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| 23ANDME HOLDING CO. | Director/Board Member | 2021-06-15 |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Consultant / Advisor | - |
Aarvik Therapeutics, Inc.
 Aarvik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aarvik Therapeutics, Inc. is a company that develops novel molecules for oncology and other diseases. The company is based in Fremont, CA. The company uses a proprietary modular platform and multiple target mechanisms and therapeutic modalities to create molecules with an improved therapeutic index. The company was founded by Sachdev Sidhu and Jagath Reddy Junutula, with Jagath Reddy Junutula serving as CEO since incorporation. | Director/Board Member | 2021-09-22 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Director/Board Member | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Corporate Officer/Principal | - |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Chairman | 2014-12-31 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Director/Board Member | 2019-07-08 |
| ░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Richard Scheller
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Richard Scheller
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| 23ANDME HOLDING CO. | Health Technology |
| Private companies | 17 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Medrio, Inc.
 Medrio, Inc. Data Processing ServicesTechnology Services Medrio, Inc. provides advanced electronic data capture and eClinical tools. It offers an integrated eClinical software platform with a fully hosted EDC system. Its new mobile suite, mSource, supports both event-based and subject-based workflows, offline data entry, and Patient Reported Outcomes (PRO). The company was founded by Michael Richard Novotny in 2005 and is headquartered in San Francisco, CA. | Technology Services |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Technology Services |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
Fine Arts Museums of San Francisco
 Fine Arts Museums of San Francisco Other Consumer ServicesConsumer Services Fine Arts Museums of San Francisco owns and operates museums. Its collections include European painting, sculpture, and decorative arts. The company is headquartered in San Francisco. CA. | Consumer Services |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Finance |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
| Affinita Biotech, Inc. | Commercial Services |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
Aarvik Therapeutics, Inc.
Aarvik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aarvik Therapeutics, Inc. is a company that develops novel molecules for oncology and other diseases. The company is based in Fremont, CA. The company uses a proprietary modular platform and multiple target mechanisms and therapeutic modalities to create molecules with an improved therapeutic index. The company was founded by Sachdev Sidhu and Jagath Reddy Junutula, with Jagath Reddy Junutula serving as CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Richard Scheller
